healthprotocol.wiki

Protocols Evidence Outcomes

therapy-immunotherapy-can-two-four-zero-nine-viral-radiotherapy

Outcomes

01
biomarker-psa-nadir-below-0-2-ng-per-milliliter-binary-measured
1 evidence row
- can-2409_0000_rct_can-2409-with-radiotherapy-for-localized-prostate-cancer-a-phase-3-randomized-placebo-controlled-clinical-trial
02
oncology-pathological-complete-response-at-2-years-binary-measured
1 evidence row
- can-2409_0000_rct_can-2409-with-radiotherapy-for-localized-prostate-cancer-a-phase-3-randomized-placebo-controlled-clinical-trial
03
safety-serious-adverse-events-count-cohort-measured
1 evidence row
- can-2409_0000_rct_can-2409-with-radiotherapy-for-localized-prostate-cancer-a-phase-3-randomized-placebo-controlled-clinical-trial
04
survival-disease-free-proportion-cohort-measured
1 evidence row
- can-2409_0000_rct_can-2409-with-radiotherapy-for-localized-prostate-cancer-a-phase-3-randomized-placebo-controlled-clinical-trial
05
survival-prostate-cancer-specific-disease-free-probability-cohort-measured
1 evidence row
- can-2409_0000_rct_can-2409-with-radiotherapy-for-localized-prostate-cancer-a-phase-3-randomized-placebo-controlled-clinical-trial

Evidence

1rows

On this page

Permalink

/protocols/therapy-immunotherapy-can-two-four-zero-nine-viral-radiotherapy

healthprotocol.wiki

A community-driven, evidence-based health registry. Built for transparency.